Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
US9051385B2 · kind B2 · utility
0Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2009 |
| Grant date | Jun 9, 2015 |
| Priority date | — |
| Expiry date | May 3, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/828
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions that comprise ARF polypeptides. ARF polypeptides and ARF polypeptide-based compositions are useful in the treatment of cancer and infectious disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.